Side-by-Side Comparison
| Metric | Harbour BioMed | Klus Pharma Inc. |
|---|---|---|
| Founded | 2016 | 2014 |
| Headquarters | Cambridge, United States | Princeton, United States |
| Employees | 113 | 11 |
| Industry | Biopharma, Biotechnology, Pharmaceutical | Manufacturing, Pharmaceutical, Marketing |
| Funding Stage | IPO | Not tracked yet |
| Total Funding | $533.80M | Not tracked yet |
| Funding Rounds | 7 | Not tracked yet |
| Business Model | Not tracked yet | Not tracked yet |
| Revenue Model | Not tracked yet | Not tracked yet |
| Services | Not tracked yet | Not tracked yet |
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | Biopharmaceutical, Antibody Therapeutics, Oncology, Immunology, Novel Antibody Discovery, Harbour Mice® Platform, Monoclonal Antibodies, Heavy Chain Only Antibodies, Immune Cell Engagers, HBICE® Technology, Transgenic Mouse Platforms, B-cell Cloning, Immuno-oncology, Inflammatory Diseases, Drug Discovery And Development | Biologics Drug Discovery And Development, Antibody Discovery, Antibody-drug Conjugates (ADC), Clinical Development, Bispecific Antibodies, Multispecific Antibodies, Immuno-oncology |
| Website | harbourbiomed.com | kluspharma.com |
About Harbour BioMed
Harbour BioMed, operating under the slogan "Healthy Life · Breakthrough Medicines," is a dynamic player in the global biopharmaceutical landscape. Established in 2016, the company has rapidly developed a strong foundation in oncology and immunology through innovative antibody therapeutics. This Uni...
About Klus Pharma Inc.
Klus Pharma Inc. is a subsidiary of Kelun Group and affiliated with Kelun-Biotech, focusing on the discovery and development of advanced therapeutic biotechnologies. Established in 2014, the company's primary aim is to address the unmet needs of patients suffering from various severe disorders such...
Frequently Asked Questions
Track both companies in real time
Signal Tracker monitors Harbour BioMed, Klus Pharma Inc., and millions of companies for 40+ signal types.